2026 NPPES data Pediatric Dermatology Physician NPI 1548255482 M.D., PH.D.
Verify on CMS →

JEFFREY SUGARMAN, M.D., PH.D.

Pediatric Dermatology Physician in SANTA ROSA, California. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
210
Medicare Part D claims · 91 beneficiaries · Pediatric Dermatology Physician avg: 497
Generic prescribing
83%
generic claims · 17% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
100/100
▲ 17 pts above national avg 83.1 · [object Object]
Industry payments
$104.5K
207 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

JEFFREY SUGARMAN, M.D., PH.D. reported a CMS MIPS final score of 100/100 — above the 83.1 national average — and filed 210 Medicare Part D claims in 2023.

100/100
MIPS score · +17 vs avg
210
Part D claims, 2023
83%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

JEFFREY SUGARMAN, M.D., PH.D.'s MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

100 Top 7% higher than 93% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). Below this entry. 80–90: 129,887 scored providers (27%). Below this entry. 90–100: 189,403 scored providers (40%). This entry sits in this band. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

JEFFREY SUGARMAN, M.D., PH.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about JEFFREY SUGARMAN, M.D., PH.D.?

High performer (top quartile)

NPI registry status

Active

Issued 09/16/2005

NPI 1548255482

Primary specialty

Pediatric Dermatology Physician

Rare

222 US NPIs in this specialty

Medicare Part D claims

210 58% vs specialty avg

2023 prescription claims

Specialty avg: 497

MIPS final score

100/100 16.900000000000006% pts

Exceptional band

vs 83.1 national avg

Specialty distribution in California

How Pediatric Dermatology Physician compares to other specialties among California providers

California providers

Pediatric Dermatology Physician share within California

1. Pediatric Dermatology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Pediatric Dermatology Physician share within California

Medicare quality performance — MIPS

JEFFREY SUGARMAN, M.D., PH.D.'s 2023 MIPS final score plotted against the Pediatric Dermatology Physician national average

High performer (top quartile)
MIPS Final Score
100/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Pediatric Dermatology Physician) — 100/100 vs national avg 83.1

0%100%National avg83%99%
MIPS final score (Pediatric Dermatology Physician) — 100/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

JEFFREY SUGARMAN, M.D., PH.D. appears in the CMS NPPES registry as a Pediatric Dermatology Physician provider holding M.D., PH.D. credentials at 2725 MENDOCINO AVE, SANTA ROSA, CA, 95403, with a listed phone of (707) 545-4537. NPI 1548255482 was issued on 09/16/2005. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what SUGARMAN most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 210 prescription claims written by this provider, covering 91 Medicare beneficiaries and totaling roughly $165K in drug spend, split 17% brand-name and 83% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 100/100 for the 2023 performance year, compared with the national average of 83.1.

Pediatric Dermatology Physician is a narrow specialty nationwide, with 222 enrolled providers across 39 states and an average of 497 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

2725 MENDOCINO AVE
SANTA ROSA, CA 95403

Provider Details

NPI 1548255482
Specialty Pediatric Dermatology Physician
Credentials M.D., PH.D.
Gender Male
NPI Issued 09/16/2005

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

100
Final Score
Avg: 83.1
100
Promoting Interoperability

Reporting: Group practice

Hospital and facility affiliations

Facilities where JEFFREY SUGARMAN, M.D., PH.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

REDWOOD FAM DERMATOLOGY MEDICAL ASSOCIATES - A MEDICAL CORPORATION
SANTA ROSA, CA

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for JEFFREY SUGARMAN, M.D., PH.D.. Source: openpaymentsdata.cms.gov.

Total received

$104.5K

Largest payer

Regeneron Healthcare Solutions, Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — California MBC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 — they are NOT specific to JEFFREY SUGARMAN, M.D., PH.D.. To verify JEFFREY SUGARMAN, M.D., PH.D.'s current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

576
Total board actions, California 2023
Across 556 cases
3.84
Actions per 1,000 licensees
California statewide rate
probation
Most common action type
186 cases

MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Typical

JEFFREY SUGARMAN, M.D., PH.D. — brand share 17.0%
Specialty average (est.)

17% brand-name claims vs 83% generic, on 210 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

210
Total Claims
$165K
Total Drug Cost
91
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
242
Total Day Supply
6,206
Brand vs Generic
17% brand / 83% generic
Brand Drug Cost
$155K
Generic Drug Cost
$9K

Patient Demographics

Average Patient Age
73.9 years
Avg HCC Risk Score
1.02
Gender Split
32% female / 68% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What JEFFREY SUGARMAN, M.D., PH.D. prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Triamcinolone Acetonide
41
Hydrocortisone
23
Clobetasol Propionate
21
Dupixent Pen
Dupilumab
16
Dupixent Syringe
Dupilumab
12
Fluocinonide
12
Tretinoin
12

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Pediatric Dermatology Physician Overview

How JEFFREY SUGARMAN, M.D., PH.D. fits within the Pediatric Dermatology Physician landscape nationally.

222
Pediatric Dermatology Physician Providers in US
39
States with Pediatric Dermatology Physician
497
Avg Claims per Provider

JEFFREY SUGARMAN, M.D., PH.D.'s 210 claims are below the specialty average of 497.

Nearby Pediatric Dermatology Physician Providers in California

Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as SUGARMAN.

Compare Pediatric Dermatology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is JEFFREY SUGARMAN, M.D., PH.D.'s specialty?
JEFFREY SUGARMAN, M.D., PH.D. specializes in Pediatric Dermatology Physician and practices in SANTA ROSA, California. Credentials: M.D., PH.D..
How much does JEFFREY SUGARMAN, M.D., PH.D. prescribe under Medicare Part D?
In 2023, JEFFREY SUGARMAN, M.D., PH.D. wrote 210 Medicare Part D claims totaling $165K in drug costs for 91 beneficiaries.
What is JEFFREY SUGARMAN, M.D., PH.D.'s Medicare quality score?
JEFFREY SUGARMAN, M.D., PH.D. has a CMS MIPS Final Score of 100/100. The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is JEFFREY SUGARMAN, M.D., PH.D. located?
JEFFREY SUGARMAN, M.D., PH.D. is located at 2725 MENDOCINO AVE, SANTA ROSA, CA, 95403. Phone: (707) 545-4537.
What is JEFFREY SUGARMAN, M.D., PH.D.'s NPI number?
JEFFREY SUGARMAN, M.D., PH.D.'s National Provider Identifier (NPI) is 1548255482, issued on 09/16/2005.
Does JEFFREY SUGARMAN, M.D., PH.D. prescribe more brand-name or generic drugs?
JEFFREY SUGARMAN, M.D., PH.D.'s prescribing is 17% brand-name and 83% generic drugs by claim count, with $155K in brand drug costs.
How many Pediatric Dermatology Physician providers are there in the US?
There are 222 Pediatric Dermatology Physician providers across 39 states in the US. The average Pediatric Dermatology Physician provider writes 497 Medicare Part D claims per year.
What drugs does JEFFREY SUGARMAN, M.D., PH.D. prescribe most often?
Based on 2023 Medicare Part D data, JEFFREY SUGARMAN, M.D., PH.D.'s most frequently prescribed drugs include Triamcinolone Acetonide, Hydrocortisone, Clobetasol Propionate. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does JEFFREY SUGARMAN, M.D., PH.D. accept Medicare?
JEFFREY SUGARMAN, M.D., PH.D. appears in CMS Medicare data with 210 Part D claims and 91 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify JEFFREY SUGARMAN, M.D., PH.D.'s credentials?
JEFFREY SUGARMAN, M.D., PH.D.'s NPI is 1548255482 with credentials M.D., PH.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology